Meghmani Finechem Limited revenues for FY21 have grown by 115% YoY, driven by higher sales of Chlor-Alkali (up 98%) and Derivatives (up 183%).  The company has delivered a strong operating and financial performance despite a challenging environment on account of the Covid pandemic. EBITDA margin expansion of 600 bps to 31% and EBITDA is165% higher at Rs. 80 crores.  FY21 revenues are 36% higher at Rs. 829 crores. Stable EBITDA margin of 32% driven by higher production and cost-efficient operations. Cash profit 12% higher at Rs. 174 crores and PAT is at Rs. 101 crores.  In FY 21, the company achieved 100% capacity utilization of chloromethanes within 2 years of operations whereas Caustic Soda and Caustic Potash operated at 80% and 83% capacity utilisation, respectively. The company has achieved 57% capacity utilisation of Hydrogen Peroxide in the first year of operations and has successfully commissioned phase 2 of the Caustic Soda plant.  The company is in the proc...